MAP 2019 - Molecular Analysis for Personalised Therapy

MAP 2019 - Molecular Analysis for Personalised Therapy is organized by European Society for Medical Oncology (ESMO), UNICANCER Group, Cancer Research UK and will be held from Nov 07 - 09, 2019 at Queen Elizabeth II Centre, Westminster, England, United Kingdom.

Description:
MAP 2019 - Molecular Analysis for Personalised Therapy is a meeting established by global opinion leaders, design to Interpreting Molecular Alterations for Clinical Practice and integrating insights from tumour samples analysis into daily practice.

The meeting is highly recommended for medical oncologists, young professionals, PhDs, academics, regulators, industry R&D representatives and investigators and all those interested in the clinical interpretation of molecular tests to providing effective cancer treatment and deliver Precision Medicine.

MAP 2019 will be the place for networking with leading academic representatives working in Precision Medicine for cancer patients.

Drug development is a fast-moving field and most of the new drugs presently in development or recently approved are driven by molecular alterations. Understanding these molecular alterations, their mechanisms of action and how they can apply to therapy is a new challenge in medical oncology and clinical practice.

Learning objectives
• To identify molecular targets in various tumour types
• To understand new concepts (like Clonal Evolution) and technologies (like Single Cell analysis)
• To illustrate how new technologies (AI, Radiomics, Digital multiplex and Computational tools) can help predicting outcome
• To access new approaches in tumour immunology besides Immune Check-point Inhibitors
• To learn how to test and use at the best knowledge of technology predictive biomarkers
• To discuss the design of innovative trials for better outcome achievements